Symbol
CRSP on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock
Latest Disclosed Ownership
8.97M shares
Security Ownership
10.5%
Shares, Excluding Options vs Price
Value, Excluding Options

ARK Investment Management LLC ownership in CRISPR Therapeutics AG Common Stock (CRSP)

2025-02-14 - ARK Investment Management LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.97M shares of CRISPR Therapeutics AG Common Stock (CRSP). This represents 10.5% percent ownership of the company. In their previous filing dated 2025-01-10, ARK Investment Management LLC had reported owning 7.5M shares, indicating an increase of 19.7% percent.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.